AARD INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Aardvark Therapeutics, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

ATLANTA, Aug. 17, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Aardvark Therapeutics, Inc. (“Aardvark”) (NASDAQ: AARD). The lawsuit alleges that Defendants, in Aardvark’s Registration Statement and throughout the Class Period, made false and misleading statements and/or failed to disclose material adverse facts, including allegations that: (i) ARD-101 was less safe than Defendants had led investors to believe; and (ii) accordingly, ARD-101’s clinical, regulatory, and commercial prospects were overstated.